This inventor holds 12 USPTO granted patents. Top assignees: Affinium Pharmaceuticals, Inc., Smithkline Beecham Corporation. Active years: 1997-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
9 out of 33 
3 out of 2,198 Years Active: 1997-2012
Title: Dalia R Jakas: Innovator in Bacterial Infection Treatment
Introduction
Dalia R Jakas is a prominent inventor based in Norristown, PA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target bacterial infections. With a total of 12 patents to her name, her work has had a substantial impact on medical research and treatment options.
Latest Patents
Among her latest patents are the Fab I inhibitors, which are compounds designed to inhibit the Fab I enzyme. These compounds are particularly useful in the treatment of bacterial infections. The innovative nature of her work in this area highlights her commitment to advancing healthcare solutions.
Career Highlights
Dalia has worked with notable companies in the pharmaceutical industry, including Affinium Pharmaceuticals, Inc. and SmithKline Beecham Corporation. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research.
Collaborations
Throughout her career, Dalia has collaborated with esteemed colleagues such as William Henry Miller and Kenneth Allen Newlander. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Dalia R Jakas is a trailblazer in the field of pharmaceutical inventions, particularly in the area of bacterial infection treatment. Her extensive patent portfolio and collaborative efforts underscore her dedication to improving healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile